Salesforce (CRM) Stock Could Be Undervalued Following Its Cresta AI Deal
Salesforce (CRM) Stock Could Be Undervalued Following Its Cresta AI Deal Simply Wall St
Covered in this story
Analyst targets on Salesforce
- Cantor Fitzgerald: at $242 · target $300 by Oct 2027 · Overweight via Investing.com
- Evercore ISI: at $242 · target $290 by Oct 2027 · Outperform via Investing.com
- Bank of America: at $241 · target $285 by Oct 2027 · Buy via Seeking Alpha
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Salesforce →Dalsna Finance is currently tracking 43 stories mentioning Salesforce, the earliest published 15 May 2017.
Summary aggregated from Simply Wall St's public RSS feed. The full reporting belongs to Simply Wall St — please read it on their site.